Baxter International Inc. has obtained two emergency use authorizations from the FDA for patients who may develop AKI during the COVID-19 pandemic.Both emergency use authorization-designated products, entitled the HF20 Set and ST Set, are intended for patients requiring continuous renal replacement therapy (CRRT), according to a company press release.
A new study finds that dupilumab is associated with an increased risk for cutaneous T-cell lymphoma in patients taking the drug for atopic dermatitis.“Dupilumab, a…
BOSTON — The emergence of infectious diseases can be tied to events like climate change, social change and political trends, according to an expert. Heather…
ATLANTA — Pregnant women with fewer economic resources may still be at elevated risk for CVD despite a low score on a CVD risk calculator,…
ATLANTA — Data from a small substudy with cardiac MRI suggest acoramidis may improve both cardiac mass and function for adults with symptomatic transthyretin amyloid…
In addition to suffering with cystic fibrosis, patients with this condition often contract lung infections that are difficult to treat; however, an upcoming study may…
The FDA has cleared an investigational new drug application for a small molecule therapeutic to treat those with Fragile X syndrome, according to the manufacturer.In…
Approximately 77,000 people in the U.S. have hypoparathyroidism due to absent or subphysiological levels of parathyroid hormone. About 75% of cases are the result of…
ATLANTA — Pregnant women with fewer economic resources may still be at elevated risk for CVD despite a low score on a CVD risk calculator,…
ATLANTA — Data from a small substudy with cardiac MRI suggest acoramidis may improve both cardiac mass and function for adults with symptomatic transthyretin amyloid…
As the eye care world approaches a possible shortage of ophthalmologists, the steady hand of robotic surgical tools could be a welcome addition for patients…
